Pain medicine for ICU patients on breathing machines
Part of Brain & nervous system clinical trials.
This study tests a pain medicine called hydromorphone to see how well it controls pain in ICU patients on breathing machines. The goal is to make patients more comfortable while they are recovering.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to be in the intensive care unit (ICU) and expected to be on a breathing machine (ventilator) for at least 24 hours.
- You (or your family) must agree to participate and sign a consent form.
- You cannot be pregnant or breastfeeding.
- You must not be allergic to opioid pain medications (like fentanyl or morphine).
- You must not have certain serious health conditions, like severe asthma, bowel blockage, liver or kidney failure, or a severe brain injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a quick-acting pain medicine (hydromorphone) given through a vein to treat severe chest pain. It may be an option for people experiencing acute pain who haven't been helped by other medicines.
This study tests a painkiller called nalbuphine for ICU patients on a breathing machine. It aims to see if it controls pain as well as or better than usual care, with fewer side effects.
This study compares different pain medicines for people in the intensive care unit (ICU) who are not on a breathing machine. The goal is to find which approach works best and is safest for managing moderate to severe pain.
This study tests a new way to manage pain and sedation for people on breathing machines in the ICU. It compares a personalized plan to usual care to see if it improves pain relief and recovery.
This study looks at pain in patients who are on a breathing machine (ventilator) in the intensive care unit. It aims to understand pain better so doctors can help manage it more effectively.
This study tests a pain-relief medicine called methoxyflurane, which you inhale through a small hand-held device, to see if it helps reduce pain from a heart attack while you're on the way to the hospital. If you qualify, you would receive this medicine in the ambulance to help you feel more comfortable.
Hear when a new Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.